Just to declare various conflicts of interest: I regard Gregg Gordon, CEO of SSRN as a friend and have always been impressed at what he has achieved at SSRN. From the perspective of what is best for the services SSRN can offer to researchers, selling to Elsevier was a smart opportunity and probably the best of the options available given the need for investment. My concerns are at the ecosystem level.